Keryx biopharmaceuticals inc (KERX)
CashFlow / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-90,838

-97,341

-162,320

-163,440

-166,795

-184,993

-143,147

-161,095

-165,095

-154,144

-136,370

-123,145

-125,646

-130,190

-125,727

-111,518

-88,901

-69,263

-58,207

-46,732

-35,692

-25,516

-15,662

-22,721

-24,468

-29,240

-30,832

-28,123

0

0

0

Adjustments to reconcile net loss to cash flows used in operating activities:
Stock-based compensation expense

20,082

19,589

18,288

18,272

14,133

14,479

14,360

13,989

14,113

14,971

15,472

16,500

26,511

30,176

28,726

26,957

17,389

9,890

7,924

5,953

2,498

2,302

2,102

2,167

2,157

2,084

2,165

2,092

0

0

0

Amortization of debt discount

-

-

-

-

-

-

-

34,227

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

-

-

-

-

-

-

-

4,718

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

975

954

960

937

918

944

973

1,005

941

833

719

596

552

501

412

306

205

120

76

54

0

0

0

-

-

-

-

-

-

-

-

Amortization of deferred lease incentive

244

245

244

244

245

244

245

244

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-down of inventory to net realizable value

8,877

8,420

7,339

3,467

13,287

25,567

28,193

27,968

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-930

-909

-890

-235

80

79

80

80

83

85

88

90

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Other current assets

-5,169

1,965

-64

8,029

12,159

6,560

7,134

340

-896

-693

-821

-1,262

1,546

1,614

2,095

2,860

-928

-99

-499

802

3,113

1,064

1,220

-104

-246

-178

381

334

0

0

0

Accounts receivable, net

5,408

6,971

6,736

2,910

9,198

3,358

1,828

1,580

-2,628

3,663

3,042

2,822

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

0

0

0

-

0

0

0

-

0

0

9,501

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in security deposits

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

0

0

0

Other assets

17,180

11,630

11,819

8,466

38

2

99

11

0

0

0

-

-

-

-

11

-45

13

54

83

0

0

0

-

-

-

-

21

0

0

0

Accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48

0

0

0

-

-

-

-

-7

0

0

0

-

-

-

-

Other current liabilities

27

27

28

28

138

116

31

-238

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

22,113

24,108

20,909

24,023

15,719

9,811

7,835

88

-9,434

-7,571

-25,585

-8,478

78

7,705

20,541

13,569

9,275

5,828

7,501

6,792

8,738

2,533

-1,105

-1,658

-2,048

2,715

3,398

3,592

0

0

0

Accrued compensation and related liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

2,355

863

212

497

70

4

24

-70

59

65

0

228

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-3,526

-1,985

1,829

3,004

3,112

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-165

-159

-151

-146

-249

-264

-278

-36

534

923

1,186

943

572

233

58

95

75

66

17

2

0

1

0

1

0

0

0

-

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-24,763

-26,822

-27,069

-25,949

-22,822

0

0

0

Net cash used in operating activities

-

-

-100,956

-

-

-

-84,839

-86,604

-90,841

-96,009

-119,909

-127,457

-136,466

-127,430

-106,231

-81,001

-59,652

-52,506

-42,227

-34,319

0

0

0

-

-

-

-

-

-

-

-

Cash flows from investing activities
Purchases of property, plant and equipment

133

889

1,335

1,257

1,186

454

37

2,074

4,409

4,653

4,753

2,777

722

867

1,329

1,489

1,496

1,087

522

346

54

66

67

24

28

26

34

57

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,188

9,236

3,279

-9,046

-4,168

0

0

0

Investment in held-to-maturity short-term securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49,771

0

0

0

-

-

-

-

11,263

11,464

11,664

14,977

9,941

0

0

0

Proceeds from maturity of held-to-maturity short-term securities

-

-

-

-

-

-

-

-

-

-

-

11,508

34,147

49,491

49,664

38,263

0

0

0

-

-

-

-

15,475

20,728

14,969

5,965

5,830

0

0

0

Net cash used in investing activities

-

-

-1,335

-

-

-

-37

-2,074

-4,409

-4,653

-4,753

8,731

33,379

44,124

48,336

-12,997

-35,597

-21,784

-50,187

-346

0

0

0

-

-

-

-

-

-

-

-

Cash flows from financing activities
Proceeds from issuance of common stock, net of commission

-2

2,595

70,640

75,720

75,722

73,125

5,080

0

0

0

0

118,284

0

0

0

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Gross proceeds from public offerings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments for common stock issuance costs

0

14

74

102

102

88

28

0

0

0

0

-

-

-

-

-

7,525

7,525

7,463

5,640

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

938

1,666

1,205

1,146

1,058

311

202

198

214

169

1,372

1,463

2,894

4,332

3,255

5,054

4,111

2,873

2,734

931

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

71,469

-

-

-

5,254

198

125,214

125,169

126,357

244,732

121,163

122,601

121,474

112,586

111,643

110,405

110,328

75,684

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33,830

0

0

0

Net (decrease) increase in cash and cash equivalents

-72,853

-91,069

-30,822

-18,284

-18,173

-15,269

-79,622

-88,480

29,964

24,507

1,695

126,006

18,076

39,295

63,579

18,588

16,394

36,115

17,914

41,019

47,490

34,779

65,643

-20,575

-17,586

-22,109

-1,165

6,840

0

0

0